Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 254

1.

Fetal skeletal muscle progenitors have regenerative capacity after intramuscular engraftment in dystrophin deficient mice.

Sakai H, Sato T, Sakurai H, Yamamoto T, Hanaoka K, Montarras D, Sehara-Fujisawa A.

PLoS One. 2013 May 9;8(5):e63016. doi: 10.1371/journal.pone.0063016. Print 2013.

2.

Extraocular muscle satellite cells are high performance myo-engines retaining efficient regenerative capacity in dystrophin deficiency.

Stuelsatz P, Shearer A, Li Y, Muir LA, Ieronimakis N, Shen QW, Kirillova I, Yablonka-Reuveni Z.

Dev Biol. 2015 Jan 1;397(1):31-44. doi: 10.1016/j.ydbio.2014.08.035. Epub 2014 Sep 16.

3.

Engraftment of embryonic stem cell-derived myogenic progenitors in a dominant model of muscular dystrophy.

Darabi R, Baik J, Clee M, Kyba M, Tupler R, Perlingeiro RC.

Exp Neurol. 2009 Nov;220(1):212-6. doi: 10.1016/j.expneurol.2009.08.002. Epub 2009 Aug 13.

4.

A new immuno-, dystrophin-deficient model, the NSG-mdx(4Cv) mouse, provides evidence for functional improvement following allogeneic satellite cell transplantation.

Arpke RW, Darabi R, Mader TL, Zhang Y, Toyama A, Lonetree CL, Nash N, Lowe DA, Perlingeiro RC, Kyba M.

Stem Cells. 2013 Aug;31(8):1611-20. doi: 10.1002/stem.1402.

5.

Muscle engraftment of myogenic progenitor cells following intraarterial transplantation.

Bachrach E, Perez AL, Choi YH, Illigens BM, Jun SJ, del Nido P, McGowan FX, Li S, Flint A, Chamberlain J, Kunkel LM.

Muscle Nerve. 2006 Jul;34(1):44-52.

PMID:
16634061
6.

Distinct roles for Pax7 and Pax3 in adult regenerative myogenesis.

Kuang S, Chargé SB, Seale P, Huh M, Rudnicki MA.

J Cell Biol. 2006 Jan 2;172(1):103-13.

7.

Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy.

Kimura E, Han JJ, Li S, Fall B, Ra J, Haraguchi M, Tapscott SJ, Chamberlain JS.

Hum Mol Genet. 2008 Aug 15;17(16):2507-17. doi: 10.1093/hmg/ddn151. Epub 2008 May 29.

8.

Assessment of the myogenic stem cell compartment following transplantation of Pax3/Pax7-induced embryonic stem cell-derived progenitors.

Darabi R, Santos FN, Filareto A, Pan W, Koene R, Rudnicki MA, Kyba M, Perlingeiro RC.

Stem Cells. 2011 May;29(5):777-90. doi: 10.1002/stem.625.

9.

Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development.

Mitchell KJ, Pannérec A, Cadot B, Parlakian A, Besson V, Gomes ER, Marazzi G, Sassoon DA.

Nat Cell Biol. 2010 Mar;12(3):257-66. doi: 10.1038/ncb2025. Epub 2010 Jan 31.

PMID:
20118923
10.

MyoD is required for myogenic stem cell function in adult skeletal muscle.

Megeney LA, Kablar B, Garrett K, Anderson JE, Rudnicki MA.

Genes Dev. 1996 May 15;10(10):1173-83.

11.

Direct isolation of satellite cells for skeletal muscle regeneration.

Montarras D, Morgan J, Collins C, Relaix F, Zaffran S, Cumano A, Partridge T, Buckingham M.

Science. 2005 Sep 23;309(5743):2064-7. Epub 2005 Sep 1.

12.

Pax3 induces differentiation of juvenile skeletal muscle stem cells without transcriptional upregulation of canonical myogenic regulatory factors.

Young AP, Wagers AJ.

J Cell Sci. 2010 Aug 1;123(Pt 15):2632-9. doi: 10.1242/jcs.061606. Epub 2010 Jul 6.

14.

Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.

Lala-Tabbert N, Fu D, Wiper-Bergeron N.

Stem Cells Transl Med. 2016 Apr;5(4):500-10. doi: 10.5966/sctm.2015-0169. Epub 2016 Mar 3.

15.

Regeneration and myogenic cell proliferation correlate with taurine levels in dystrophin- and MyoD-deficient muscles.

McIntosh LM, Garrett KL, Megeney L, Rudnicki MA, Anderson JE.

Anat Rec. 1998 Oct;252(2):311-24.

PMID:
9776086
16.

Alveolar rhabdomyosarcoma-associated proteins PAX3/FOXO1A and PAX7/FOXO1A suppress the transcriptional activity of MyoD-target genes in muscle stem cells.

Calhabeu F, Hayashi S, Morgan JE, Relaix F, Zammit PS.

Oncogene. 2013 Jan 31;32(5):651-62. doi: 10.1038/onc.2012.73. Epub 2012 Jun 18.

PMID:
22710712
17.

Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells.

Dellavalle A, Sampaolesi M, Tonlorenzi R, Tagliafico E, Sacchetti B, Perani L, Innocenzi A, Galvez BG, Messina G, Morosetti R, Li S, Belicchi M, Peretti G, Chamberlain JS, Wright WE, Torrente Y, Ferrari S, Bianco P, Cossu G.

Nat Cell Biol. 2007 Mar;9(3):255-67. Epub 2007 Feb 11.

PMID:
17293855
18.

A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.

Li S, Kimura E, Ng R, Fall BM, Meuse L, Reyes M, Faulkner JA, Chamberlain JS.

Hum Mol Genet. 2006 May 15;15(10):1610-22. Epub 2006 Apr 4.

PMID:
16595609
19.

Isolation of myogenic progenitor populations from Pax7-deficient skeletal muscle based on adhesion characteristics.

Lu A, Cummins JH, Pollett JB, Cao B, Sun B, Rudnicki MA, Huard J.

Gene Ther. 2008 Aug;15(15):1116-25. doi: 10.1038/gt.2008.86. Epub 2008 May 29.

PMID:
18509381
20.

Engraftment of mesenchymal stem cells into dystrophin-deficient mice is not accompanied by functional recovery.

Gang EJ, Darabi R, Bosnakovski D, Xu Z, Kamm KE, Kyba M, Perlingeiro RC.

Exp Cell Res. 2009 Sep 10;315(15):2624-36. doi: 10.1016/j.yexcr.2009.05.009. Epub 2009 May 19.

PMID:
19460366

Supplemental Content

Support Center